Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.48 (
transcriptase
)
9,479
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Influenza A virus RNA synthesis is catalyzed by the viral polymerase comprised of the PA, PB1, and
PB2 proteins
. We show that the host
DDX21
RNA helicase restricts influenza A virus by binding PB1 and inhibiting polymerase assembly, resulting in reduced viral RNA and protein synthesis. Later during infection, the viral NS1 protein overcomes this restriction by binding to
DDX21
and displacing PB1.
DDX21
binds to a region of the NS1 N-terminal domain that also participates in other critical functions. A virus mutant whose NS1 protein is unable to bind
DDX21
exhibits reduced viral protein synthesis at both late and early times of infection, a phenotype converted to wild-type upon
DDX21
knockdown. As sequential interaction of PB1 and NS1 with
DDX21
leads to temporal regulation of viral gene expression, influenza A virus likely uses the
DDX21
-NS1 interaction not only to overcome restriction, but also to regulate the viral life cycle.
...
PMID:Cellular DDX21 RNA helicase inhibits influenza A virus replication but is counteracted by the viral NS1 protein. 2472 76